ABL90 FLEX Analyzer REF 393090 UDI:05700693930909
FDA Device Recall #Z-2320-2019 — Class II — July 10, 2019
Recall Summary
| Recall Number | Z-2320-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 10, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Radiometer America Inc |
| Location | Brea, CA |
| Product Type | Devices |
| Quantity | 13,042 units |
Product Description
ABL90 FLEX Analyzer REF 393090 UDI:05700693930909
Reason for Recall
Software Security; The action is being initiated because of software security vulnerabilities with the firm's analyzer operating system, which may cause the device to shutdown or reboot resulting in delayed medical treatment.
Distribution Pattern
US: AB, AL, AR, BC, CA, CO, CT, FL, GA, IA, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NH, NJ, NY, OH, OK, OR, PA, SC, TX, VA, VT, WA, WI, WV OUS: Canada, Netherland, China, Czech Republic, Denmark, Germany, Spain, France, Hugary, , indiat Japan, South Korea, United Kingdom, Australia, Poland, South Africa, Singapore, Switzerland, Turkey, Norway, Austria, Italy, Sweden, Finland, Brazil, and Mexico
Lot / Code Information
All lots with the operating system versions - RXPE -UIM2743 v1.3XXXXXX or RXPE-UIM910 v1.3.XXXXXX
Other Recalls from Radiometer America Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0682-2019 | Class II | ABL800 analyzer, model numbers 393-800 and 393-... | Jul 3, 2018 |
| Z-0801-2019 | Class II | Product: ABL800 FLEX with Crea. The ABL800 with... | Jul 2, 2018 |
| Z-0010-2019 | Class II | ABL90 FLEX analyzers with software versions 3.3... | May 25, 2018 |
| Z-0231-2018 | Class II | ABL800 analyzer with FLEXQ module. Device in... | Oct 24, 2017 |
| Z-3237-2017 | Class II | AutoCheck5+, Level 2, specifically designed for... | Sep 7, 2017 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.